title: Understanding clinic options for overactive bladder.
abstract: Overactive bladder (OAB) is a symptom complex of urinary frequency, nocturia and urgency with or without urgency incontinence that adversely impacts patient's quality of life. Conservative management begins in the outpatient clinic, often with significant improvement and patient satisfaction. In this review we will discuss the evaluation of OAB and review treatment options focusing on behavioral modification, medical therapy, and neuromodulation. These treatment options are offered in a stepwise fashion, remembering that more than one may be needed and can be used concomitantly.
authors.affiliation: William Beaumont Hospital Women's Urology Center, 3601 West 13 Mile Road, 2-South, Royal Oak, MI, 48073, USA, Jamie.Bartley@beaumont.edu.
authors.forename: Jamie M
authors.initials: JM
authors.lastname: Bartley
authors.forename: Emily S
authors.initials: ES
authors.lastname: Blum
authors.forename: Larry T
authors.initials: LT
authors.lastname: Sirls
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Peters
mesh_terms: D058667:Adrenergic beta-3 Receptor Agonists / Q000627:therapeutic use*; D000553:Ambulatory Care; D001521:Behavior Therapy; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D004599:Electric Stimulation Therapy; D006801:Humans; D058542:Implantable Neurostimulators; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010353:Patient Education as Topic; D053201:Urinary Bladder, Overactive / Q000175:diagnosis / Q000628:therapy*
chemical_list: D058667:Adrenergic beta-3 Receptor Agonists; D018727:Muscarinic Antagonists; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A